Evidence map›Paper›PMID 29864375›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.

Jun-Chieh J Tsay, Benjamin G Wu, Michelle H Badri, Jose C Clemente, Nan Shen, Peter Meyn, Yonghua Li, Ting-An Yie, Tenzin Lhakhang, Evan Olsen and 12 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 286 papers.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 433 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Jun-Chieh J Tsay1 Division of Pulmonary and Critical Care Medicine.ORCID 0000-0002-2282-2510
Benjamin G Wu1 Division of Pulmonary and Critical Care Medicine.
Michelle H Badri2 Flatiron Institute, Center for Computational Biology, Simons Foundation, New York, New York.
Jose C Clemente3 Department of Genetics and Genomic Sciences and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Nan Shen3 Department of Genetics and Genomic Sciences and Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Peter Meyn4 New York University Genomic Technology Center, New York, New York; and.
Yonghua Li1 Division of Pulmonary and Critical Care Medicine.
Ting-An Yie1 Division of Pulmonary and Critical Care Medicine.
Tenzin Lhakhang4 New York University Genomic Technology Center, New York, New York; and.
Evan Olsen1 Division of Pulmonary and Critical Care Medicine.
Vivek Murthy1 Division of Pulmonary and Critical Care Medicine.
Gaetane Michaud1 Division of Pulmonary and Critical Care Medicine.
Imran Sulaiman1 Division of Pulmonary and Critical Care Medicine.
Aristotelis Tsirigos4 New York University Genomic Technology Center, New York, New York; and.
Adriana Heguy4 New York University Genomic Technology Center, New York, New York; and.
Harvey Pass5 Department of Cardiothoracic Surgery, and.
Michael D Weiden1 Division of Pulmonary and Critical Care Medicine.
William N Rom1 Division of Pulmonary and Critical Care Medicine.
Daniel H Sterman1 Division of Pulmonary and Critical Care Medicine.
Richard Bonneau2 Flatiron Institute, Center for Computational Biology, Simons Foundation, New York, New York.
Martin J Blaser7 Department of Medicine, New York University School of Medicine, New York, New York.
Leopoldo N Segal1 Division of Pulmonary and Critical Care Medicine.ORCID 0000-0003-3559-9431
Pulmonary and Critical Care Associates · USNew York University · USIcahn School of Medicine at Mount Sinai · USSimons Foundation · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL, HOCHMAN, JUDITH S · 2012 to 2014
$16.8M
NYU Lung Cancer Biomarker CenterU01CA086137 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROM, WILLIAM N · 2000 to 2015
$15.3M
Research Training for Physician-Scientists in Gastrointestinal OncologyT32CA193111 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAR-SAGI, DAFNA, WOLFGANG, CHRISTOPHER L. · 2015 to 2024
$2.7M
Lung Microbiome and Inflammation in Early COPDK23AI102970 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGAL, LEOPOLDO NICOLAS · 2014 to 2017
$754k
NCATS NIH HHS UL1 TR000038NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NCI NIH HHS T32 CA193111NCI NIH HHS U01 CA086137NIAID NIH HHS K23 AI102970
6 · The paper itself

Abstract

rationaleIn lung cancer, upregulation of the PI3K (phosphoinositide 3-kinase) pathway is an early event that contributes to cell proliferation, survival, and tissue invasion. Upregulation of this pathway was recently described as associated with enrichment of the lower airways with bacteria identified as oral commensals.

objectivesWe hypothesize that host-microbe interactions in the lower airways of subjects with lung cancer affect known cancer pathways.

methodsAirway brushings were collected prospectively from subjects with lung nodules at time of diagnostic bronchoscopy, including 39 subjects with final lung cancer diagnoses and 36 subjects with noncancer diagnoses. In addition, samples from 10 healthy control subjects were included. 16S ribosomal RNA gene amplicon sequencing and paired transcriptome sequencing were performed on all airway samples. In addition, an in vitro model with airway epithelial cells exposed to bacteria/bacterial products was performed. MEASUREMENTS AND MAIN

resultsThe composition of the lower airway transcriptome in the patients with cancer was significantly different from the control subjects, which included up-regulation of ERK (extracellular signal-regulated kinase) and PI3K signaling pathways. The lower airways of patients with lung cancer were enriched for oral taxa (Streptococcus and Veillonella), which was associated with up-regulation of the ERK and PI3K signaling pathways. In vitro exposure of airway epithelial cells to Veillonella, Prevotella, and Streptococcus led to upregulation of these same signaling pathways.

conclusionsThe data presented here show that several transcriptomic signatures previously identified as relevant to lung cancer pathogenesis are associated with enrichment of the lower airway microbiota with oral commensals.

Indexed as

AdultAgedBronchoscopyCross-Sectional StudiesFemaleHumansLung NeoplasmsMaleMicrobiotaMiddle AgedPhosphatidylinositol 3-KinasesProspective StudiesRespiratory SystemUp-RegulationPhosphatidylinositol 3-Kinasesbronchoscopylung cancermicrobiome

Identifiers

PMID29864375
PMCPMC6221574
OpenAlexW2806389440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.